Company Number: 14157068

Analysis Date: 2025-07-29 16:16 UTC

Financial Health Assessment Report for FINXROBES LIMITED

---

1. Financial Health Score: C (Fair)

Explanation:
FINXROBES LIMITED exhibits signs of recovery and stabilization from a previous period of financial distress. The latest financial year shows positive net current assets and shareholders’ funds, moving from negative values in prior years. However, the margin remains thin, and current liabilities are still high relative to current assets. This suggests caution is warranted, as the company’s financial "vital signs" are improving but not yet robust.

---

2. Key Vital Signs

Metric	2024 (£)	2023 (£)	Interpretation
Current Assets	121,209	34,958	Significant increase, indicating improved liquidity.
Cash	39,321	19,769	Cash reserves have doubled, a healthy sign of cash flow.
Debtors	23,986	9,261	Increase in receivables; needs monitoring for collection efficiency.
Current Liabilities	109,659	35,829	Large increase, could indicate higher short-term obligations.
Net Current Assets	11,550	(871)	Positive net working capital after previous deficit; improving operational liquidity.
Shareholders’ Funds	11,550	(872)	Equity has turned positive, indicating return to a solvent position.
Number of Employees	3	0	Business growth reflected in staff hiring.

Interpretation:

• The company’s liquidity position ("healthy cash flow") is notably better than prior year, reflected by increased cash and net current assets.
• The jump in current liabilities is a "symptom of distress" that warrants attention, as it may indicate growth financed by short-term debt or delayed payments to creditors.
• Positive shareholders’ funds show the company’s net worth has improved, moving from a negative "balance sheet fever" state to a more stable footing.
• The rise in debtors requires ongoing monitoring to prevent cash flow bottlenecks.

---

3. Diagnosis: Financial Condition

• Liquidity: Improving but fragile. The company now holds net current assets rather than liabilities, suggesting it can cover short-term debts with available resources. However, the high current liabilities relative to cash and debtors pose some risk of liquidity strain if receivables slow or creditors demand payment sooner.
• Solvency: The company has moved from a negative equity position to positive shareholders’ funds, indicating an overall healthier balance sheet and solvency. This is a good recovery sign for a young company incorporated in 2022.
• Growth Indicators: Increase in employees and assets (notably stocks and debtors) suggests business expansion. However, this "growth spurt" has also increased liabilities, which must be carefully managed.
• Risk Factors: The company is still small, with limited operating history. The lack of an audited accounts report means financials are unaudited, so slight caution in interpreting the figures is prudent.

In medical terms, the company was previously in a "financial fever" state (negative equity and working capital) but is now showing signs of "convalescence" with improving liquidity and solvency. Yet, the "symptoms" of elevated short-term liabilities and growing receivables need vigilant monitoring to avoid relapse.

---

4. Recommendations

• Cash Flow Management: Tighten credit control procedures to ensure debtors are collected promptly, improving liquidity and reducing risk of cash flow distress.
• Liability Review: Review and negotiate payment terms with creditors to spread out short-term liabilities and avoid cash crunches.
• Cost Control: Monitor operating expenses carefully, especially with new employees, to ensure that growth does not outpace sustainable revenue.
• Financial Planning: Develop a rolling cash flow forecast to anticipate potential liquidity gaps and plan financing accordingly.
• Consider External Funding: If growth continues rapidly, consider securing longer-term finance to reduce reliance on short-term creditors.
• Audit Consideration: Although currently exempt, consider voluntary audit or independent review to enhance financial credibility with lenders and investors.
• Regular Financial Check-ups: Schedule quarterly financial reviews to track key metrics and promptly address any new "symptoms" of distress.

---